DAA Therapy in Hepatitis C in Patients With Chronic Kidney Disease: New Information for GFR Category G4 and G5 Reply

被引：0
|
作者：
Awan, Ahmed A. [1 ]
Jadoul, Michel [1 ]
Martin, Paul [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2022年 / 20卷 / 01期
关键词：
D O I：
10.1016/j.cgh.2021.03.033
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：247 / 247
页数：1
相关论文
共 50 条
  • [1] DAA Therapy in Hepatitis C in Patients With for GFR Category G4 and G5
    Dai, Chia-Yen
    Huang, Jee-Fu
    Chuang, Wan-Long
    Yu, Ming-Lung
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (01) : 246 - 247
  • [2] Hyperchloremic acidosis develops at the stage G4 and shifts to high anion gap acidosis at the stage G5 in chronic kidney disease
    Masayuki Tanemoto
    Ryohei Kamachi
    Takahide Kimura
    Seiki Yamada
    Takeshi Yokoyama
    Yukio Okazaki
    Clinical and Experimental Nephrology, 2020, 24 : 1140 - 1143
  • [3] Hyperchloremic acidosis develops at the stage G4 and shifts to high anion gap acidosis at the stage G5 in chronic kidney disease
    Tanemoto, Masayuki
    Kamachi, Ryohei
    Kimura, Takahide
    Yamada, Seiki
    Yokoyama, Takeshi
    Okazaki, Yukio
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2020, 24 (12) : 1140 - 1143
  • [4] Prevalence and incidence of chronic kidney disease stage G5 in Japan
    Kunihiro Yamagata
    Takashi Yagisawa
    Shigeru Nakai
    Masaaki Nakayama
    Enyu Imai
    Motoshi Hattori
    Kunitoshi Iseki
    Takashi Akiba
    Clinical and Experimental Nephrology, 2015, 19 : 54 - 64
  • [5] Prevalence and incidence of chronic kidney disease stage G5 in Japan
    Yamagata, Kunihiro
    Yagisawa, Takashi
    Nakai, Shigeru
    Nakayama, Masaaki
    Imai, Enyu
    Hattori, Motoshi
    Iseki, Kunitoshi
    Akiba, Takashi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2015, 19 (01) : 54 - 64
  • [6] THE USEFULNESS OF TOLVAPTAN IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE WITH CHRONIC KIDNEY DISEASE STAGE G3 TO G4
    Yamada, Kazunori
    Muramoto, Hiroaki
    Araki, Hideo
    Kakuchi, Yasushi
    Miyagi, Kyoko
    Kitajima, Susumu
    Tani, Yukiko
    Onoe, Tamehito
    Hirata, Masayoshi
    Takeda, Masahiro
    Miyazaki, Ryoichi
    Kawano, Mitsuhiro
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 360 - 360
  • [7] Promotor methylation: Does it affect response to therapy in chronic hepatitis C (G4) or fibrosis?
    Zekri, Abdel-Rahman N.
    Raafat, Ahmed M.
    Elmasry, Suzan
    Bahnassy, Abeer A.
    Saad, Yasmin
    Dabaon, Hamed A.
    El-Kassas, Mohamed
    Shousha, Hend I.
    Nassar, Auhood A.
    EL-Dosouky, Mohamed Ale
    Hussein, Nehal
    ANNALS OF HEPATOLOGY, 2014, 13 (05) : 518 - 524
  • [8] Inpatient educational program delays the need for dialysis in patients with chronic kidney disease stage G5
    Takagi, Wei Han
    Osako, Kiyomi
    Machida, Shinji
    Koitabashi, Kenichiro
    Shibagaki, Yugo
    Sakurada, Tsutomu
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2021, 25 (02) : 166 - 172
  • [9] Inpatient educational program delays the need for dialysis in patients with chronic kidney disease stage G5
    Wei Han Takagi
    Kiyomi Osako
    Shinji Machida
    Kenichiro Koitabashi
    Yugo Shibagaki
    Tsutomu Sakurada
    Clinical and Experimental Nephrology, 2021, 25 : 166 - 172
  • [10] The Effect of Proton Pump Inhibitor Use on the Course of Kidney Function in Patients with Chronic Kidney Disease Stages G3a to G4
    Giusti, Sixto
    Lin, Yilu
    Sogbetun, Folarin
    Nakhoul, Nazih
    Liu, Shuqian
    Shi, Lizheng
    Batuman, Vecihi
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2021, 362 (05): : 453 - 461
12345